1 ANNEX, Commission Regulation (EU) No 759/2010 of 24 August 2010 amending the Annex to Regulatio…

In forcesince 24 Aug 2010

In Table 1 of the Annex to Regulation (EU) No 37/2010, the following substance is inserted in alphabetical order:

Pharmacologically active substance | Marker residue | Animal species | MRL | Target tissues |

Other provisions

(according to Article 14(7) of Regulation (EC) No 470/2009)

Therapeutic classification

‘Tildipirosin | Tildipirosin | Bovine, caprine | 400 μg/kg | Muscle |

Not for use in animals from which milk is produced for human consumption.

The MRL for muscle shall not apply to the injection site, where residue levels shall not exceed 11500 μg/kg.

Provisional MRL shall expire on 1 January 2012.

Macrolide’

200 μg/kg | Fat

2000 μg/kg | Liver

3000 μg/kg | Kidney

Porcine | 1200 μg/kg | Muscle |

The MRL for muscle shall not apply to the injection site, where residue levels shall not exceed 7500 μg/kg.

Provisional MRL shall expire on 1 January 2012.

800 μg/kg | Skin and fat

5000 μg/kg | Liver

10000 μg/kg | Kidney